![Sayenko Kharenko](/cdn-cgi/image/width=256/https://www.legal500.com/profiles/wp-content/uploads/sites/13/2024/03/sk_tag_navy_red.png)
Sayenko Kharenko
sk.ua sk.uaLawyers
![Valentyna Hvozd](/cdn-cgi/image/width=256/https://www.legal500.com/wp-content/uploads/sites/13/2023/07/17344_1153127.jpg)
Valentyna Hvozd
- Phone+38 044 499 6000
- Email[email protected]
- Social
Work Department
Antitrust/Competition, Corporate and M&A, Intellectual Property.
Position
Valentyna Hvozd, partner at Sayenko Kharenko, is focusing on antitrust and competition matters. She also practices corporate law, M&A, privatization, and intellectual property law.
Ms Hvozd regularly advises clients on a wide range of antitrust law matters, including merger control (mergers and acquisitions, and joint ventures), cartels, abuse of dominance, antitrust investigations and advice, distribution agreements, and unfair competition before the Antimonopoly Committee of Ukraine. She has extensive experience advising multinational and domestic clients on the most complex and high profile cases requiring profound knowledge and an innovative approach to meet the client's expectations.
Her recent work highlights have included representations of:
AbbVie Inc. in its acquisition of Shire plc (54.7 billion USD) Archer-Daniels-Midland Company in its acquisition of WILD Flavors GmbH and WILD Dairy Ingredients GmbH (2.2 billion EUR) Berkshire Hathaway Inc. in its acquisition of Duracell business from The Procter & Gamble Company (4.7 billion USD) Berkshire Hathaway in its acquisition of Precision Castparts (37.2 billion USD) China National Chemical Corporation in its acquisition of Pirelli & C. S.p.A. (7.1 billion EUR) Cinven and Bain Capital in their acquisition of Stada (4.1 billion EUR) Concerted practices clearance for MTIBU re new system for claims settlement Dell in its acquisition of EMC (67 billion USD) Diebold in its acquisition of Wincor Nixdorf Konecranes in its acquisition of Terex business Merck KGaA in its acquisition of Sigma-Aldrich Corporation (17 billion USD) PartnerRe Ltd. and AXIS Capital Holdings Limited in their merger (11 billion USD) One Equity Partners in its acquisition of Duran Group Holding GmbH (93 million USD) Perrigo Company in its acquisition of Omega Pharma Invest NV (3.6 billion EUR) Royal Dutch Shell in its acquisition of BG Group (47 billion GB pounds) Solvay S.A. in its acquisition of Chevron Phillips Chemical Company assets Solvay SA in its acquisition of Cytec (5.5 billion USD)